PELLEGRITI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.857
AS - Asia 1.502
EU - Europa 1.424
AF - Africa 225
SA - Sud America 202
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.215
Nazione #
US - Stati Uniti d'America 2.763
CN - Cina 658
SG - Singapore 642
IT - Italia 554
IE - Irlanda 254
UA - Ucraina 205
BR - Brasile 182
CI - Costa d'Avorio 180
DE - Germania 134
KR - Corea 91
CA - Canada 83
RU - Federazione Russa 69
SE - Svezia 42
GB - Regno Unito 38
IN - India 35
SN - Senegal 30
FI - Finlandia 26
NL - Olanda 21
VN - Vietnam 16
FR - Francia 15
CZ - Repubblica Ceca 14
PL - Polonia 10
AT - Austria 8
CH - Svizzera 8
TR - Turchia 8
UZ - Uzbekistan 8
AR - Argentina 7
BD - Bangladesh 7
MX - Messico 7
ES - Italia 6
HK - Hong Kong 6
AZ - Azerbaigian 5
BE - Belgio 5
CO - Colombia 5
JP - Giappone 4
LB - Libano 4
NG - Nigeria 4
PK - Pakistan 4
ZA - Sudafrica 4
BG - Bulgaria 3
CL - Cile 3
IQ - Iraq 3
RO - Romania 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
EU - Europa 2
GR - Grecia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
EC - Ecuador 1
GA - Gabon 1
GE - Georgia 1
ID - Indonesia 1
IM - Isola di Man 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.215
Città #
Santa Clara 587
Singapore 454
Chandler 406
Hefei 258
Dublin 254
Chicago 219
Jacksonville 192
Abidjan 180
Houston 179
Boardman 139
Seoul 91
Civitanova Marche 89
Catania 87
Beijing 81
Ashburn 79
Grafing 76
Cambridge 69
Andover 67
Lawrence 67
Nanjing 67
Toronto 56
Wilmington 40
Dakar 30
San Mateo 30
Des Moines 29
Nanchang 26
Los Angeles 24
Munich 24
Rome 23
The Dalles 22
Council Bluffs 21
Hebei 21
Pescara 21
Saint Petersburg 21
Ottawa 20
Columbus 19
Bari 18
Shenyang 17
Brooklyn 15
Kochi 15
São Paulo 15
Bremen 14
Messina 14
Brno 12
Misterbianco 12
New York 12
Changsha 11
Helsinki 11
Quintano 11
Palermo 10
Seattle 10
Turku 10
Amantea 9
Dearborn 9
Dong Ket 9
San Francisco 9
Aci Castello 8
Iserlohn 8
Jiaxing 8
Naples 8
Norwalk 8
Woodbridge 8
Padova 7
Crema 6
Dallas 6
Jinan 6
Moscow 6
Parma 6
Pune 6
Rio de Janeiro 6
Tianjin 6
Agrigento 5
Ann Arbor 5
Brussels 5
Enna 5
Hong Kong 5
Stockholm 5
Abuja 4
Atlanta 4
Baku 4
Boston 4
Campinas 4
Capo d'Orlando 4
Carrara 4
Den Haag 4
Fairfield 4
Falls Church 4
Frankfurt am Main 4
Genoa 4
Lappeenranta 4
Mexico City 4
Milan 4
Modena 4
Montreal 4
Ningbo 4
Tokyo 4
Valledolmo 4
Vienna 4
Villafranca Tirrena 4
Warsaw 4
Totale 4.536
Nome #
Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different Outcomes 247
Chemioterapia con fluorouracile (FU) in infusione continua e vinorelbina (VNB) nel carcinoma differenziato della tiroide (CDT) in fase avanzata 125
Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis 110
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 110
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 98
Absorbed Dose Evaluation in Radioiodine Therapy with Different Approaches 95
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 94
A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma 90
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases 89
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 89
Soggetti trattati con chemio e/o radioterapia in età pediatrica per neoplasia: patologia tiroidea (morfo-funzione) 86
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors 86
Caratteristiche istologiche alla diagnosi e decorso clinico in pazienti tiroidectomizzati per carcinoma papillare variante sclerosante diffusa: studio di metanalisi. 83
Persistenza vs Recidiva di malattia nel Carcinoma Differenziato della Tiroide 83
[Differentiated carcinoma of the thyroid in the young. Clinical and histopathologic aspects] 82
Caratteristiche cliniche e istologiche di una serie di 23 pazienti affetti da carcinoma tiroideo della cisti del dotto tireoglosso 80
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 80
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution 79
Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods 79
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 77
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 76
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 76
Risk of benign and malignant thyroid disorders in subjects treated for paediatric/adolescent neoplasia: Role of morphological and functional screening 76
Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries 75
BRAF(V600E) mutation and the biology of papillary thyroid cancer 75
Differentiated thyroid cancer in children and adolescents 75
Caratteristiche istologiche e cliniche della variante sclerosante diffusa del carcinoma papillifero tiroideo 74
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 74
Orbital metastasis from thyroid cancer: a case report and review of the literature 73
EP-1773 Radioiodine therapy: a dosimetric study in a patient with DTC after rhTSH stimulation 72
Papillary thyroid cancer incidence in the volcanic area of Sicily 71
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome 71
Outcome of differentiated thyroid cancer in Graves' patients 71
Several site-specific cancers are increased in the volcanic area in Sicily 70
Increased mortality in patients with differentiated thyroid cancer associated with graves' disease 70
Long-term outcome of patients with insular carcinoma of the thyroid 70
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 70
Heavy Metals in the Environment and Thyroid Cancer 68
Lymph node location is a risk factor for papillary thyroid cancer-related death 67
L’ipertiroidismo è un fattore di rischio di trombosi venosa e arteriosa: descrizione di un caso clinico 66
Ruolo prognostico dello status linfonodale alla diagnosi sull’evoluzione clinica di 4292 pazienti tiroidectomizzati per carcinoma differenziato della tiroide (CDT). 66
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes" 65
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 64
Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment 64
Risk-stratified evaluation of over 16000 thyroid microcarcinomas: at presentation more than one third have two or more risk factors for recurrence. 62
Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension. 61
Thyroid cancer in thyroglossal dust cyst requires a specific approach due to its unpredictable extension. 59
Mortality of differentiated thyroid cancer in Graves’s patients. 59
The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels 58
Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer 58
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 58
Is multifocality a risk factor in low-risk papillary thyroid cancer? 57
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. 55
Valore predittivo del dosaggio della tireoglobulina sierica alla prima valutazione post-tiroidectomia nei pazienti con carcinoma papillifero della tiroide di piccole dimensioni 54
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. 53
Utilità del dosaggio ultrasensibile della tireoglobulina per il follow-up dei pazienti con carcinoma tiroideo differenziato classificati per livello di rischio di recidiva. 52
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM 51
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients 51
TSH ricombinante umano nei pazienti con carcinoma tiroideo differenziato: utilità del follow-up a breve e a lungo termine 51
Chemotherapy with continous infusion of fluorouracil (FU) and vinorelbine (VNB) in advanced differentiated thyroid cancer (DTC) 50
Evidenza RMN di metastasi orbitaria da carcinoma papillifero tiroideo avanzato: rara osservazione successiva a remota chemio- e radioterapia per Linfoma non Hodgkin 49
Metastatic malignant struma ovarii with coexistence of Hashimoto’s thyroiditis 49
Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol 48
Thyroglobulin measurements after rhTSH stimulation in the follow-up of patients with differentiated thyroid cancer 48
Occurrence of distant metastates as the first sign of disease is a strong prognostic factor of poor outcome in patients with differentiated thyroid cancer 48
Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review 47
Prognostic factors for adrenocortical carcinoma outcomes 47
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. 47
Prognostic significance of serum Tg in differentiated thyroid cancer (DTC) patients before 131-I ablation and its correlation with neck 131-I uptake. 47
Update on thyroid cancer treatment 46
Ruolo della 18FDG PET nel follow-up del carcinoma differenziato della tiroide (CDT) in presenza di valori di Tireoglobulina (Tg) indosabili, AAT elevati e TBS post-131-I negativo: esperienza clinica in una paziente 45
Thyroid Tumor Registry of Sicily: Molecular Epidemiology 45
Usefulness of rhTSH in the management of differentiated thyroid cancer 45
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 44
Giant parathyroid adenoma: a rare cause of primary hyperparathyroidism mimicking a carcinoma 44
Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer 43
Proposta di modifica della stadiazione TNM dei pazienti con carcinoma tiroideo a bass rischio (stadio I). 43
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 42
The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival 42
Predictive factors of persistent disease in a large cohort of pediatric patients with differentiated thyroid carcinoma 40
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: A 2015 position statement of the Italian Society of Endocrinology 40
Long-term outcome in patients with differentiated thyroid cancer and skull metastases 40
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 39
Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study 39
Usefulness of recombinant human TSH (rhTSH) in the radiometabolic treatment of selected thyroid cancer patients 39
The influence of the environment on the development of thyroid tumors: A new appraisal 37
Response: Re: Papillary thyroid cancer incidence in the volcanic area of sicily 37
Antioxidant Defense Capacity Is Reduced in Thyroid Stem/Precursor Cells Compared to Differentiated Thyrocytes 37
Cardiac arrest after intravenous calcium administration for calcitonin stimulation test 37
Type I gastric carcinoid in a young woman with polyglandular autoimmune syndrome type III. 2013 36
Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging 35
Pancreatic Neuroendocrine Tumors: Experience from a Single Institute 35
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer 35
Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: A retrospective analysis of 74 families 34
Gestione del carcinoma tiroideo in età pediatrica [Management of thyroid carcinoma in the paediatric age] 33
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 32
Descriptive epidemiology of human thyroid cancer: Experience from a regional registry and the "volcanic factor" 31
False positive 131I total body scan due to bilateral polycystic renal disease 30
Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine 28
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium 28
Totale 6.161
Categoria #
all - tutte 23.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021437 0 31 42 7 106 13 41 8 104 7 46 32
2021/2022484 60 70 3 12 71 2 73 17 46 0 15 115
2022/20231.056 71 67 16 135 98 153 19 193 235 8 32 29
2023/2024671 30 94 20 33 23 166 0 76 9 15 74 131
2024/20252.341 26 372 162 144 475 296 69 69 120 183 201 224
2025/2026641 349 292 0 0 0 0 0 0 0 0 0 0
Totale 6.362